Immune reconstitution inflammatory syndrome in HIV-infected patients with mycobacterial infections starting highly active anti-retroviral therapy.

AIM To describe the radiological appearances of immune reconstitution inflammatory syndrome (IRIS) in human immunodeficiency virus (HIV)-infected patients with mycobacterial infections starting highly active anti-retroviral therapy (HAART). MATERIALS AND METHODS Five consecutive HIV infected patients with IRIS due to mycobacterial infection were studied. Intercurrent infection and poor drug compliance were excluded as causes of presentation. The chest radiological appearances at the time of starting HAART and at the time of diagnosis of IRIS were compared. RESULTS In these five patients there was clinical and radiological deterioration, occurring between 10 days and 7 months after starting HAART, leading to unmasking of previously undiagnosed mycobacterial infection or to worsening of mycobacterial disease. All five patients had HAART-induced increases in CD4+ T lymphocyte counts and reductions in peripheral blood HIV "viral load". Chest radiographic abnormalities due to IRIS included marked mediastinal lymphadenopathy in three patients-severe enough to produce tracheal compression in two patients (one of whom had stridor)-and was associated with new pulmonary infiltrates in two patients. The other two patients had new infiltrates, which in one patient was associated with a pleural effusion. CONCLUSION These cases illustrate the diverse chest radiographic appearances of IRIS occurring after HAART in patients with mycobacterial and HIV co-infection. Marked mediastinal lymphadenopathy occurred in three of these five patients (with associated tracheal narrowing in two patients); four patients developed pulmonary infiltrates and one had an effusion. The cases further highlight that the onset of IRIS may be delayed for several months after HAART is started.

[1]  J. Jernigan,et al.  Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy , 2002, International journal of STD & AIDS.

[2]  C. O'Mahony,et al.  Focal adenitis developing after immune reconstitution with HAART , 2000, International journal of STD & AIDS.

[3]  M. Narita,et al.  Pulmonary tuberculosis in AIDS patients: transient chest radiographic worsening after initiation of antiretroviral therapy. , 2000, AJR. American journal of roentgenology.

[4]  S. Padley,et al.  Imaging of the thorax in AIDS , 2002 .

[5]  E. Girardi,et al.  Radiological patterns in HIV-associated pulmonary tuberculosis: comparison between HAART-treated and non-HAART-treated patients. , 2003, Clinical radiology.

[6]  S. Hasegawa,et al.  [A case of isoniazid-induced pneumonitis]. , 1998, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

[7]  R. Chaisson,et al.  Paradoxical worsening of tuberculosis in HIV-infected persons. , 2001, Chest.

[8]  D. Zoumboulakis,et al.  Transitory exacerbation of fever and roentgenographic findings during treatment of tuberculosis in children. , 1955, American review of tuberculosis.

[9]  I. Campbell,et al.  Lymph node tuberculosis: a comparison of various methods of treatment. , 1977, Tubercle.

[10]  G. Satten,et al.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. , 1998, The New England journal of medicine.

[11]  M. Narita,et al.  Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. , 1998, American journal of respiratory and critical care medicine.

[12]  M. Tanimoto,et al.  Pneumonitis induced by rifampicin , 2002, Thorax.

[13]  P. Rudge,et al.  PARADOXICAL EXPANSION OF INTRACRANIAL TUBERCULOMAS DURING CHEMOTHERAPY , 1984, The Lancet.

[14]  S. Lau,et al.  Clinical Spectrum of Paradoxical Deterioration During Antituberculosis Therapy in Non-HIV-Infected Patients , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[15]  P. Kvale,et al.  Incidence of Tuberculosis in the United States among HIV-Infected Persons , 1997, Annals of Internal Medicine.

[16]  H. Smith Paradoxical responses during the chemotherapy of tuberculosis. , 1987, The Journal of infection.

[17]  A. Mocroft,et al.  Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection , 1999, The Lancet.

[18]  D. Neau,et al.  Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment , 1998, AIDS.

[19]  Horsburgh Cr Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. , 1991, The New England journal of medicine.

[20]  B. Roca,et al.  Superior vena cava syndrome during the treatment of pulmonary tuberculosis in an HIV-1 infected patient. , 2000, The Journal of infection.

[21]  Caroline A Sabin,et al.  The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy , 2003, AIDS.

[22]  G. Scott,et al.  Acute respiratory distress related to chemotherapy of advanced pulmonary tuberculosis: a study of two cases and review of the literature. , 1986, The Quarterly journal of medicine.

[23]  P. Boiselle,et al.  The Imaging Spectrum of Pulmonary Tuberculosis in AIDS , 2002, Journal of thoracic imaging.

[24]  Alimuddin Zumla,et al.  Impact of HIV infection on tuberculosis , 2000, Postgraduate medical journal.

[25]  M A Fischl,et al.  A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. , 1997, The New England journal of medicine.

[26]  E. Kohner,et al.  BROMOCRIPTINE AND SERUM-GROWTHHORMONE LEVELS IN DIABETES MELLITUS , 1975, The Lancet.

[27]  R. Pomerantz,et al.  Inflammatory Reactions in HIV-1Infected Persons after Initiation of Highly Active Antiretroviral Therapy , 2000, Annals of Internal Medicine.